Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 36.00
-0.35 (-0.96%)
At close: Aug 28, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 3.97 billion as of August 28, 2026.
Market Cap
3.97B
Enterprise Value
3.70B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
ChartMarket Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has decreased from 4.62B to 3.97B, a decrease of -14.11%. That is a compound annual growth rate of -18.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 3.90B | -6.53% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 21.09B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.98B |
| Intelligene | 7.54B |
| Uwell Biopharma | 6.85B |
| Tripartite Therapeutics | 4.71B |
| Pet Pharm Biotech | 3.49B |
| BIONET Therapeutics | 2.25B |
| FullHope Biomedical | 1.40B |